AMHN Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
AMHN Inc
TickerTXMD
CIK #0000025743
CUSIP88338N206
SectorEnergy & Transportation - Crude Petroleum & Natural Gas
Address100 N First St Suite 104, Burbank, CA 91502
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
TherapeuticsMD Inc 2023-07-11 1.1 M Exemption: 506(b) · Remaining: $3,850,002 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0000025743] 10-K
[0000025743] 10-Q
[0000025743] 3
[0000025743] 4
[0000025743] 5
[0000025743] 8-K
[0000025743] D
[0000025743] SC 13D
[0000025743] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Baselake Partners LP TherapeuticsMD Inc [2026-04-06] 0.0
Clearline Capital LP TherapeuticsMD Inc [2025-02-12] 0.0
Clearline Capital LP TherapeuticsMD Inc [2024-11-12] 5.52
Rubric Capital Management LP TherapeuticsMD Inc [2022-08-08] 18.27
Beryl Capital Management LLC TherapeuticsMD Inc [2022-06-03] 1.5
Flynn James E TherapeuticsMD Inc [2021-07-07] 4.9
Vanguard Group Inc TherapeuticsMD Inc [2018-02-09] 5.26
Franklin Resources Inc TherapeuticsMD Inc [2017-02-07] 5.7
BlackRock Inc TherapeuticsMD Inc [2017-01-30] 5.6
JPMorgan Chase & Co TherapeuticsMD Inc [2017-01-25] 6.8
Price T Rowe Associates Inc /MD/ TherapeuticsMD Inc [2016-02-12] 5.8
Bank of New York Mellon Corp TherapeuticsMD Inc [2015-02-10] 6.37
RA Capital Management LLC TherapeuticsMD Inc [2014-02-14] 8.0
Gilder Gagnon Howe & Co LLC TherapeuticsMD Inc [2014-02-12] 5.21
[2013-05-03] None
[2013-05-03] None
[2013-05-02] None
FMR LLC TherapeuticsMD Inc [2013-02-14] 0.0
[2013-02-04] None
[2013-02-04] None
[2012-12-04] None
[2012-12-04] None
[2012-10-02] None
[2012-10-02] None
[2012-07-20] None
[2012-07-20] None
[2012-07-02] None
[2012-07-02] None
[2012-06-21] None
[2012-06-21] None
[2012-04-17] None
[2012-04-17] None
[2012-04-17] None
[2012-02-28] None
[2012-02-28] None
Wellington Management Co LLP TherapeuticsMD Inc [2012-02-14] 6.16
Form 3/4/5 Filer 2011 - 2026
Thompson Tommy G
TherapeuticsMD Inc
Walker Marlan D
Collins Cooper C
Naughton Gail K
Rosen David Efraim
Rubric Capital Management LP
Ziegler Joseph
Donegan Michael C
Bernick Brian
Glickman Mark A
Musing Jules A
Russell Angus C
Bisaro Paul
Ling Karen
Roberts Justin Hunter
O'Dowd Hugh
DArecca James
Carroll J Martin
Finizio Robert G
Borkowski Edward
Milligan John CK IV
Krassan Mitchell
Cartwright Daniel A
Barlow Jane F
LaPenta Robert V Jr
Segal Nicholas
Stanicky Randall S
Greco Samuel A
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Thompson Tommy G
Common Stock
2025-12-23 Buy 8,400 $1.67 14,028
Walker Marlan D
Non-Qualified Stock Option (right to buy) · derivative
2025-11-03 Grant 67,492 $0.00
Thompson Tommy G
Restricted Stock Units · derivative
2025-11-03 Grant 8,500 $0.00
Collins Cooper C
Restricted Stock Units · derivative
2025-11-03 Grant 8,500 $0.00
Naughton Gail K
Restricted Stock Units · derivative
2025-11-03 Grant 8,500 $0.00
Walker Marlan D
Common Stock
2025-04-14 Buy 490 $1.00 490
Thompson Tommy G
Common Stock
2025-04-14 Buy 325 $1.00 325
Walker Marlan D
Common Stock
2025-04-10 Buy 1,167 $0.86 1,004
Walker Marlan D
Common Stock
2025-04-09 Buy 1,136 $0.87 988
Walker Marlan D
Common Stock
2025-02-18 Option exercise 3,467 $0.00
Walker Marlan D
Restricted Stock Units · derivative
2025-02-18 Option exercise 2,311 $0.00
Walker Marlan D
Performance Stock Units · derivative
2025-02-18 Option exercise 3,467 $0.00
Walker Marlan D
Common Stock
2025-02-18 Option exercise 1,733 $0.00
Walker Marlan D
Restricted Stock Units · derivative
2025-02-18 Option exercise 770 $0.00
Walker Marlan D
Common Stock
2025-02-18 Option exercise 770 $0.00
Walker Marlan D
Restricted Stock Units · derivative
2025-02-18 Option exercise 1,733 $0.00
Naughton Gail K
Common Stock
2025-02-18 Option exercise 8,500 $0.00
Collins Cooper C
Restricted Stock Units · derivative
2025-02-18 Option exercise 8,500 $0.00
Naughton Gail K
Restricted Stock Units · derivative
2025-02-18 Option exercise 8,500 $0.00
Thompson Tommy G
Common Stock
2025-02-18 Option exercise 8,500 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 50 3,960,688
2025-12-31 45 3,441,970
2025-09-30 46 3,304,262
2025-06-30 45 3,306,713
2025-03-31 44 3,361,440
2024-12-31 42 3,536,008
2024-09-30 39 3,391,139
2024-06-30 39 3,418,461
2024-03-31 44 3,648,184
2023-12-31 42 3,421,380
2023-09-30 39 3,038,105
2023-06-30 44 3,092,835
Form 13F Holdings
Firm Period DFND Voting Shares
Activest Wealth Management [2026-06-30] SOLE 0 40
Farther Finance Advisors LLC [2026-06-30] SOLE 0 39
IFP Advisors LLC [2026-06-30] SOLE 21 21
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com